Kazutoshi Maruyama

Title: Kazutoshi Maruyama: Innovator in Oral Drug Delivery Systems

Introduction

Kazutoshi Maruyama is a notable inventor based in Maebashi, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of oral dosage forms for biologically active proteins. His innovative work aims to enhance the effectiveness and practicality of drug delivery systems.

Latest Patents

Kazutoshi Maruyama holds a patent for an oral dosage form of biologically active proteins. This patent includes a formulation comprising granulocyte colony stimulating factor or erythropoietin, surfactants, fatty acids, and enteric materials. The invention addresses the challenge of inactivation of the principal ingredient during pharmaceutical manufacturing. It also enhances the absorption of the active ingredient from the intestinal tract, particularly due to the inclusion of fatty acids. This advancement allows for dosage reductions, facilitates accurate dose control, and increases the practical usefulness of bioactive proteins.

Career Highlights

Kazutoshi Maruyama is associated with Kirin-Amgen, Inc., where he continues to contribute to innovative drug development. His work focuses on improving oral drug formulations, which are crucial for patient compliance and therapeutic efficacy.

Collaborations

Kazutoshi collaborates with Hideaki Nomura, leveraging their combined expertise to advance research and development in the pharmaceutical industry.

Conclusion

Kazutoshi Maruyama's contributions to oral dosage forms of biologically active proteins represent a significant advancement in pharmaceutical technology. His innovative approach enhances drug delivery systems, making them more effective and user-friendly.